Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized,Double-blind,Double-dummy,Multiple-dose Parallel Control,Multiple Centers Study to Assess the Safety and Dose-range of Metacavir Enteric-coated Capsules for Patients With Chronic Hepatitis B

NCT02965859 is registered in ClinicalTrials.gov with Guangzhou Yipinhong Pharmaceutical CO.,LTD as lead sponsor.

NCT NCT02965859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02965859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized,Double-blind,Double-dummy,Multiple-dose Parallel Control,Multiple Centers Study to Assess the Safety and Dose-range of Metacavir Enteric-coated Capsules for Patients With Chronic Hepatitis B
Lead sponsor
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2012
Completion date
Not reported
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b